| Dr Caliste Iv Hsu, MD | |
|
1 Edmundson Pl, Suite 500, Council Bluffs, IA 51503-4619 | |
| (712) 323-5333 | |
| (712) 323-3252 |
| Full Name | Dr Caliste Iv Hsu |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 20 Years |
| Location | 1 Edmundson Pl, Council Bluffs, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972620912 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Clarinda Regional Health Center | Clarinda, IA | Hospital |
| Cass County Memorial Hospital | Atlantic, IA | Hospital |
| Myrtue Medical Center | Harlan, IA | Hospital |
| Chi Health Mercy Council Bluffs | Council bluffs, IA | Hospital |
| Methodist Jennie Edmundson | Council bluffs, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Miller Orthopaedic Affiliates Pc | 4385533769 | 11 |
| Miller Orthopaedic Affiliates Pc | 4385533769 | 11 |
| Shelby County Chris A Myrtue Memorial Hospital | 5193619393 | 37 |
| Cass County Memorial Hospital | 5294634994 | 59 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
New analysis from a mental health care study shows that "coordinated specialty care" (CSC) for young people with first episode psychosis is more cost-effective than typical community care. Cost-effectiveness analysis in health care is a way to compare the costs and benefits of two or more treatment options.
With today's release of a landmark study by the Institute of Medicine (IOM), Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C, finding that inadequate public-health resources are being allocated to national and local prevention, control, and surveillance programs, the National Viral Hepatitis Roundtable (NVHR) today renewed its call for the Administration, Congress, and the entire health care system to take immediate and decisive action to implement the report's key recommendations.
Ironwood Pharmaceuticals, Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to the proposed initial public offering of shares of its Class A common stock. The number of shares to be offered and the price range for the offering have not yet been determined.
The troubles with the health website took center stage on the Sunday news shows and in the Saturday weekly addresses from the president and the Republicans.
› Verified 5 days ago
| Entity Name | Miller Orthopaedic Affiliates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659379519 PECOS PAC ID: 4385533769 Enrollment ID: O20041122000880 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
New analysis from a mental health care study shows that "coordinated specialty care" (CSC) for young people with first episode psychosis is more cost-effective than typical community care. Cost-effectiveness analysis in health care is a way to compare the costs and benefits of two or more treatment options.
With today's release of a landmark study by the Institute of Medicine (IOM), Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C, finding that inadequate public-health resources are being allocated to national and local prevention, control, and surveillance programs, the National Viral Hepatitis Roundtable (NVHR) today renewed its call for the Administration, Congress, and the entire health care system to take immediate and decisive action to implement the report's key recommendations.
Ironwood Pharmaceuticals, Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to the proposed initial public offering of shares of its Class A common stock. The number of shares to be offered and the price range for the offering have not yet been determined.
The troubles with the health website took center stage on the Sunday news shows and in the Saturday weekly addresses from the president and the Republicans.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Caliste Iv Hsu, MD 1 Edmundson Pl, Suite 500, Council Bluffs, IA 51503-4619 Ph: (712) 323-5333 | Dr Caliste Iv Hsu, MD 1 Edmundson Pl, Suite 500, Council Bluffs, IA 51503-4619 Ph: (712) 323-5333 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
New analysis from a mental health care study shows that "coordinated specialty care" (CSC) for young people with first episode psychosis is more cost-effective than typical community care. Cost-effectiveness analysis in health care is a way to compare the costs and benefits of two or more treatment options.
With today's release of a landmark study by the Institute of Medicine (IOM), Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C, finding that inadequate public-health resources are being allocated to national and local prevention, control, and surveillance programs, the National Viral Hepatitis Roundtable (NVHR) today renewed its call for the Administration, Congress, and the entire health care system to take immediate and decisive action to implement the report's key recommendations.
Ironwood Pharmaceuticals, Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to the proposed initial public offering of shares of its Class A common stock. The number of shares to be offered and the price range for the offering have not yet been determined.
The troubles with the health website took center stage on the Sunday news shows and in the Saturday weekly addresses from the president and the Republicans.
› Verified 5 days ago
Dr. Gregory Vincent Stanislav, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 933 E Pierce St Ste 206, Council Bluffs, IA 51503 Phone: 712-396-7460 Fax: 712-396-7465 | |
Ardith A Ryberg, MD Surgery Medicare: Medicare Enrolled Practice Location: 801 Harmony St, Suite 408, Council Bluffs, IA 51503 Phone: 712-256-6160 Fax: 402-895-5060 | |
Dr. Patrick Ahrens, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 201 Ridge St, Suite 214, Council Bluffs, IA 51503 Phone: 712-396-4320 Fax: 712-396-4328 | |
David Mortensen, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 Mercy Dr Ste 220, Council Bluffs, IA 51503 Phone: 712-388-2660 | |
Mrs. Stacey Elizabeth Burmeister, Surgery Medicare: Accepting Medicare Assignments Practice Location: 201 Ridge St, Suite 206, Council Bluffs, IA 51503 Phone: 712-396-7460 Fax: 712-396-7465 | |
Dr. Michael Zlomke, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 201 Ridge St, Suite 214, Council Bluffs, IA 51503 Phone: 712-396-4320 Fax: 712-396-4328 |